302 related articles for article (PubMed ID: 22008447)
1. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
[TBL] [Abstract][Full Text] [Related]
2. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
[TBL] [Abstract][Full Text] [Related]
3. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
[TBL] [Abstract][Full Text] [Related]
4. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
6. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
[TBL] [Abstract][Full Text] [Related]
7. Late-onset major depression: clinical and treatment-response variability.
Driscoll HC; Basinski J; Mulsant BH; Butters MA; Dew MA; Houck PR; Mazumdar S; Miller MD; Pollock BG; Stack JA; Schlernitzauer MA; Reynolds CF
Int J Geriatr Psychiatry; 2005 Jul; 20(7):661-7. PubMed ID: 16021664
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
10. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
Cohen RM; Greenberg JM; IsHak WW
JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
[TBL] [Abstract][Full Text] [Related]
11. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
[TBL] [Abstract][Full Text] [Related]
12. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ
Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860
[TBL] [Abstract][Full Text] [Related]
14. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
15. Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study.
Denninger JW; van Nieuwenhuizen AO; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ; Gollan JK; Pizzagalli DA; Fava M
J Nerv Ment Dis; 2011 Oct; 199(10):807-10. PubMed ID: 21964277
[TBL] [Abstract][Full Text] [Related]
16. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
Habra ME; Baker B; Frasure-Smith N; Swenson JR; Koszycki D; Butler G; van Zyl LT; Lespérance F
J Psychosom Res; 2010 Aug; 69(2):133-41. PubMed ID: 20624511
[TBL] [Abstract][Full Text] [Related]
17. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
Sakurai H; Suzuki T; Yoshimura K; Mimura M; Uchida H
Psychopharmacology (Berl); 2017 Aug; 234(16):2453-2461. PubMed ID: 28470399
[TBL] [Abstract][Full Text] [Related]
18. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
Trivedi MH; Lin EH; Katon WJ
CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
Langworth S; Bodlund O; Agren H
J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
